L-Dopa decreases cutaneous nociceptive inhibition of motor activity in Parkinson's disease

Acta Neurologica Scandinavica

Volumn 105, Issue 3, 2002, Pages 196-201

  Serrao, M ^a   Parisi, L ^a   Valente, G ^a   Martini, A ^a   Fattapposta, F ^a   Pierelli, F ^b   Rossi, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

A delta fibers; Cutaneous silent period; L Dopa; Parkinson's disease; Spinal interneurons

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; HUMAN; INTERNEURON; MALE; MOTOR ACTIVITY; MUSCLE RIGIDITY; NERVE STIMULATION; NOCICEPTION; PARKINSON DISEASE; SPINAL CORD NERVE CELL;

ADMINISTRATION, ORAL; AGED; ANTIPARKINSON AGENTS; FEMALE; HAND; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; PAIN; PARKINSON DISEASE; SPINAL NERVES;

EID: 0036201115     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.1o085.x     Document Type: Article

References (38)

1. Peripherally induced EMG silent periods. Normal physiology and disorders of motor control
2. Silent period induced by cutaneous stimulation
3. Relationship between stimulus strength and cutaneous silent period
4. Conduction abnormalities detected by silent period testing
5. Spinal motor neuron excitability during the cutaneous silent period
6. Silent period in upeer limb muscles after noxious cutaneous stimulation in man
7. Mechanisms underlying spinal motor neuron excitability during the cutaneous silent period in humans
8. Cutaneous electromyographic silent period findings in brachial dystonia
9. The electromyographic silent period in Huntington's chorea - A comparison between childhood and adult values
10. The electromyographic silent period is reduced in individuals at risk for Huntington's disease
11. Silent periods, long-latency reflexes and cortical MEPs in Huntington's disease and at-risk relatives
12. The silent period in spastic, rigid and normal subjects during isotonic and isometric muscle contractions
13. Levodopa in parkinsonism: Reduction of the electromyographic silent period and its relationship with tremor
14. Silent periods in the abductor pollicis brevis muscle in patients with Parkinson's disease
15. Parkinson's disease rigidity: Magnetic motor evoked potentials in a small hand muscle
16. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation
17. Repetitive transcranial magnetic stimulation causes a short-term increase in the duration of the cortical silent period in patients with Parkinson's disease
18. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism
19. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: Evidence from transcranial magnetic stimulation
20. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
21. Consensus on the diagnosis of multi-system atrophy
22. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop
23. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
24. Afterdischarge activity in neuropathic patients with frequent muscle cramps
25. Presynaptic inhibition of muscle and tendon organ afferents in the mammalian spinal cord
26. Convergence of descending and various peripheral inputs onto common propriospinal-like inputs in man
27. Interneurones mediating presynaptic inhibition of group II muscle afferents in the cat spinal cord
28. Cutaneous reflexes in Parkinson's disease
29. Apomorphine can increase cutaneous inhibition of motor activity in Parkinson's disease
30. Cutaneous silent period
31. On the central generation of locomotion in the low spinal cat
32. Stimulation-induced setting of postural muscle tone in the decerebrate rat
33. Bistable characteristics of motoneurone activity during DOPA induced fictive locomotion in spinal cats
34. Existence of new dopaminergic terminal plexus in the rat spinal cord: Assessment by immunohistochemistry using anti-dopamine serum
35. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease
36. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease
37. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects
38. Primate models of movement disorders of basal ganglia origin